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candidate BM212 was reported to be active against Mtb with an
MIC of 1.5 mg/mL.BM212 belongs to the MmpL3 class of inhibitors
which stops the transport of mycolic acids.
Methods & Materials: The structural similarity between an
MmpL3 inhibitor BM212 and a cannabinoid receptor modulator
rimonabant prompted us to investigate the anti-tubercular activity
of rimonabant and its analogues. Accordingly several compounds
were synthesized and their activity was evaluated against Mtb.
Results: Further optimization, particularly through incorpo-
ration of silicon into the scaffold resulted in new compounds
with signiﬁcant improvement in anti-tubercular activity against
Mycobacterium tuberculosis (H37Rv).
Repurposing of rimonabant
Conclusion: A sila analogue turned out to be the most potent
antimycobacterial compound (MIC, 31 ng/mL) from this serieswith
an excellent selectivity index. Optimization of the series to improve
its ADME properties is currently in progress.
http://dx.doi.org/10.1016/j.ijid.2016.02.870
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Background: Mycobacterium tuberculosis infection of the eye is
common in India, but the orbital infection is extremely rare. Orbital
tuberculosis occurs as a result of hematogenous spread or direct
extension from the neighboring structures. In this study we have
reviewed the clinical and microbiology features of orbital tubercu-
losis.
Methods & Materials: Medical and Microbiology records of
patients with orbital tuberculosis positive for M.tuberculosis in cul-
ture between June 2010 and May 2015 reviewed. The study data
included demographic details of the patients, clinical presentation,
interventions and reports of other investigations performed. Inci-
sion biopsy/Pus aspirate/FNAC specimen obtained from patients
were subjected to direct microscopy by Ziehl Neelsen staining,
inoculated on to Lowenstein Jensen(LJ) medium and histopathol-
ogy.
Results:A total of 6patientswithorbital tuberculosiswere iden-
tiﬁedduring the studyperiod. Fourof sixpatientswere females. The
age ranges of the patients from 7 years to 29 years. Four patients
were less than 15 years, two patients were within 15 to 30 years.
All the patients were immunocompetent. Two patients presented
with lacrimal gland mass with proptosis, one patient with chronic
orbital cellulitis, one patient with orbital cellulitis and tuberculosis
osteomyelitis, one with upper lid mass with choroidal granuloma
and one patient with upper lid mass. Mantoux test was performed
in 4/6 patients and positive in all the four patients. Chest Xwas per-
formed in 5/6 patients and no abnormality was noted in all these
patients.ESRwaselevated in3/5patients.Histopathologydiagnosis
was available for 5 patients and 4/5 patients showed granuloma-
tous inﬂammation with caseous necrosis , one with tuberculosis
osteomyelitis. Direct smear was positive for acid fast bacilli and
culture grew Mycobacterium tuberculosis on LJ medium in all the
patients. All the patients were started on anti tuberculosis treat-
ment.
Conclusion: Orbital tuberculosis should be considered as a
differential diagnosis in immunocompetent patients with orbital
swelling and abscess in TB endemic countries. In majority of
patients orbital tuberculosis occurswithout systemic involvement.
http://dx.doi.org/10.1016/j.ijid.2016.02.871
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Background: Despite the availability of highly efﬁcacious treat-
ment for decades, tuberculosis (TB) remains a major global health
problem. The widespread transmission of resistant variants of
Mycobacterium tuberculosis, which does not respond to any of the
commercial drugs, threatens health security of both developed
and developing world. The urgent need of new antimycobacterial
agents and development pathways is becoming more and more
apparent.
Methods & Materials: More than 200 new diverse struc-
tures, including more than 50 new synthetic chiral compounds
derived from natural terpenoids (+)-camphor and (-)-fenchone
were synthesized. The compounds were evaluated for their in vitro
antimycobacterial activity by proportional method against ref-
erence strain Mycobacterium tuberculosis H37Rv and multidrug
resistant Mycobacterium tuberculosis strain 43.
Results: Thequantitative structure–activity relationship (QSAR)
revealed several structural requirements: two hydrogen bond
donors, two or three rings and no large branched substituents. We
describe the design of a set of nine novel camphane-based deriva-
tives following these requirements. Four of them showed activities
in the nanomolar range, signiﬁcantly higher than the activities in
the initial set. Many structures showed promising antimycobacte-
rial activity (MIC up to 0.27M) – 10 to 20 fold higher than activity
of ethambutol in combination with insigniﬁcant cytotoxicity (IC50
more than 354 M toward human embryonal kidney cell line).
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Conclusion: When developing new drugs against Mycobac-
terium tuberculosis, it is important to note that this bacteria has
a solid and chemically resistant cell wall. Therefore, anti-TB agents
are speciﬁc and do not act on other pathogenic bacteria, and vice
versa - the huge variety of available antibiotics does not affect
the mycobacteria. For all tested compounds there is no correla-
tion between their antimycobacterial activity and activity against
other microorganisms. This indicates that the action of all potent
derivatives ((+)-camphor and (-)-fenchones) are speciﬁc to the
Mycobacteriumtuberculosis.All of themare stable, non-toxic against
human cells and show antimycobacterial activity in the nanomolar
range being 60 times more active than ethambutol.These results
can be considered an important starting point for design of new
effective antitubercular drugs.
http://dx.doi.org/10.1016/j.ijid.2016.02.872
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Background: Tuberculosis is an infectious disease causedby the
bacillusMycobacterium tuberculosis. Mycobacteremia is a key event
in the pathogenesis of tuberculosis and development of extra-
pulmonary TB. Genotyping of M. tuberculosis isolates is useful for
surveying the dynamics of TB infection, identifying new outbreaks,
and preventing the disease. We attempted to estimate the preva-
lence of M. tuberculosis bacteremia and its genotypes.
Methods & Materials: Suspected cases of tuberculosis were
screened formycobacteremia by culturing 5ml of peripheral blood
sample in the MB/BacT® culture system (bioMérieux, France).
Flashed positive bottles were screened for M. tuberculosis using in-
house multiplex PCR and further screened for drug susceptibility.
All isolates were subjected to spoligotyping, 24 loci MIRU-VNTR,
TbD1+/1 and RD analysis. Genotyping analysiswas performed using
SIT-VIT web and MIRU-VNTRplus online tools.
Results: Blood culture was performed from 469 patients (306
extrapulmonary, 50 pulmonary and 113 disseminated TB cases).
Seventy seven (16.4%) of these blood cultures were positive by
MB/BacT®. Of the 77 isolates, 36 (11.7%) were patients had extra-
pulmonary TB, 34 (30%) disseminated TB, and 7 (14%) pulmonary
tuberculosis. Among the culture positives 67 (87%) were identiﬁed
as M. tuberculosis and 10 (13%) as mycobacteria other than tuber-
culosis using in-house multiplex PCR. Spoligotyping identiﬁed 65
isolates (97%) belong to 16 previously described Share Types, while
the remaining two isolates had unique/un-identiﬁed Share Types
patterns based upon SIT-VIT web. Among them ST26 (CAS1 DEL)
was more predominant (49.2%) followed by ST25 (CAS1 DEL)
(9.2%), ST1 (Beijing) (9.2%) andST19 (EAI2 MANILLA) (7.6%). Largest
number of clustering of isolateswas detected in Beijing (100%), CAS
(97.4%), and EAI (81.8%) by spoligotyping. TbD1 analysis showed
that majority of the isolates (83.5%) were modern lineages (TbD1¯)
and 11 (16.4%) isolates belong to ancient linage (TbD1+). All the
ancient lineage isolates belong to EAI lineage.
Conclusion: CAS lineage was predominantly found among
mycobacteremiapatients. This pattern is notdifferent fromthepre-
dominance of mycobacterial isolates genotyped from pulmonary
TB cases.
http://dx.doi.org/10.1016/j.ijid.2016.02.873
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Background: The problems with any PCR method using DNA
sequences as targets for ampliﬁcation include false-positive results,
the inability to detect a difference between viable and nonvi-
able organisms and the inability to determine drug susceptibility.
Instead of DNA detecting assays, using RT-qPCR to assess the
expression of the 85B mRNA gene of M. tuberculosis indicates the
presence of a viable organism. In this study, we used the mRNA
coding for 85B antigen complex which is present in all mycobac-
teria. We aimed to assess the diagnostic performance of RT-qPCR
method by comparing with the real-time PCR Cobas TaqMan MTB
kit.
Methods & Materials: A total of 54 cases including 32 (17
males, 15 females) patientswith conﬁrmed tuberculosis and 22 (13
males, 9 females) individualswithout tuberculosiswere includedas
patient and control groups, respectively. Themean ages of 30males
and 24 females were 37,06 ± 8,88 and 36,75 ± 8,96, respectively.
Decontamination with N-acetyl-L-cysteine and sodium hydrox-
ide (NALC–NaOH) at 2% and Mycobacterial Growth Indicator Tube
(MGIT) 960 system was used for the laboratory diagnosis of spu-
tum samples. Decontaminated samples were used for the manual
extraction of M. tuberculosis DNA and 85B mRNA. Extracted DNA
was used for Cobas TaqManMTBDNA qPCR kit (Roche Diagnostics)
in a cobas TaqMan 48 analyzer. For RT-qPCR method, total RNA
was extracted from the sputum specimen using standard TRIzol
protocol (Invitrogen) and 85B mRNA analyses were performed on
LightCycler 480 II system.
Results: A signiﬁcant difference was detected between patients
and control groups by RT-qPCR method (p<0.001) and Cobas Taq-
ManMTBDNA qPCR kit (p=0.0027). Sensitivity, speciﬁcity, positive
and negative predictive values and kappa coefﬁcient were deter-
mined as 97%, 95%, 97%, 95%, 0.89% for RT-qPCR method and 91%,
